Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
59
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
33
users have liked this narrative
6
users have commented on this narrative
89
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CyberAgent
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Japan Privacy Laws And Global Tech Giants Will Limit Outcomes
Key Takeaways Regulatory pressures, fierce competition, and changing demographics threaten CyberAgent's core ad and media businesses, putting downward pressure on growth and profit margins. Reliance on hit game titles and costly expansion into original content creates unpredictable earnings, increasing risk if user or revenue growth falters.
View narrative
JP¥1.20k
FV
33.2% overvalued
intrinsic discount
2.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Kokusai Electric
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Chinese Exposure And Rising Compliance Costs Will Shadow Future Chip Equipment While Minor Upsides Emerge
Key Takeaways Overdependence on a concentrated Chinese customer base and rising in-house equipment development by key clients threaten revenue stability and long-term market share. Stricter global regulations and slower technological advancement intensify cost pressures and limit growth, with industry headwinds casting doubt on sustained profitability.
View narrative
JP¥2.80k
FV
9.7% overvalued
intrinsic discount
7.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Babcock International Group
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
UK And European Cuts Will Shrink Revenue Amid Tech Rivalry
Key Takeaways Reliance on major government contracts, especially in defense, exposes Babcock to revenue risks from budget cuts, procurement changes, or market shifts toward new technologies. Ongoing legacy contract losses, high capital and pension costs, and limited financial flexibility threaten margins, cash flow, and dividend sustainability.
View narrative
UK£7.50
FV
27.7% overvalued
intrinsic discount
4.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
IONOS Group
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Mega-scale Cloud Providers Will Squeeze Margins And Market Share
Key Takeaways Intensifying competition from dominant cloud providers, coupled with weak differentiation and price wars, threatens IONOS's market share and long-term profitability. Increased regulatory complexity and reliance on vulnerable SME segments expose IONOS to higher costs, shrinking margins, and heightened risks of revenue stagnation or decline.
View narrative
€32.00
FV
27.8% overvalued
intrinsic discount
7.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Embracer Group
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Rising Integration Challenges And Global Regulatory Pressures Will Erode Stability
Key Takeaways Persistent post-acquisition integration issues and reliance on a few hit AAA titles threaten earnings stability, profitability, and margin predictability. Structural industry shifts, higher production costs, and regulatory risks undermine growth prospects and pressure Embracer's large, acquisition-focused strategy.
View narrative
SEK 93.00
FV
10.6% overvalued
intrinsic discount
-1.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Persol HoldingsLtd
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Japan's Aging Workforce And Tech Rivals Will Pressure Recruitment Performance
Key Takeaways Accelerating automation, demographic shifts, and tech-driven competition threaten the firm's traditional staffing model, putting pressure on both revenue growth and profitability. Heavy reliance on the domestic market and slow overseas expansion expose earnings to local risks, while unsuccessful innovation and acquisitions could further weaken performance.
View narrative
JP¥233.00
FV
31.1% overvalued
intrinsic discount
5.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
16 days ago
author updated this narrative
LG Uplus
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Aging Korean Demographics And OTT Will Squeeze Telecom Margins
Key Takeaways Demographic shifts and changing consumer habits challenge core telecom revenue, putting long-term growth and ARPU under significant pressure. High investment in innovation and diversification faces risks from rising compliance costs and industry price pressures, threatening margins and sustainable earnings.
View narrative
₩10.00k
FV
45.9% overvalued
intrinsic discount
0.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Nanya Technology
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
DRAM Headwinds And Geopolitical Risks Will Constrain Outlook
Key Takeaways Technology lag and limited access to advanced memory markets constrain profitability, while industry shifts toward integrated solutions threaten core business relevance. Regulatory pressures, geopolitical risks, and scale disadvantages increase operational volatility, challenging long-term growth and margin sustainability.
View narrative
NT$30.20
FV
45.5% overvalued
intrinsic discount
29.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Gland Pharma
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
ESG Costs And Regulatory Delays Will Damage Legacy Generics
Key Takeaways Heavy reliance on traditional generics, regulatory approvals, and concentrated geographies increases vulnerability to revenue volatility and margin compression. Rising ESG requirements and intensifying price competition are set to erode margins and constrain reinvestment capacity.
View narrative
₹1.14k
FV
70.0% overvalued
intrinsic discount
13.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Value any company in seconds
Popular companies